Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP961661priorityCriticalpatent/ECSP961661A/es
Publication of ECSP961661ApublicationCriticalpatent/ECSP961661A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
El invento se refiere al suministro de un método para tratar un acondición asociada con la modulación del receptor muscarínico usando una formulación transdémica de 3-[4-(butiltio)-1,2,5-tiadiazol-3-il] -azabiciclo-[2.2.2] octano. La invención suministra formulaciones transdérmicas de parche deseadas de 3-[4-(butiltio)-1,2,5-tiadiazol-3-il] -1- azabiciclo -[2.2.2]octano.